Citation Impact
Citing Papers
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
2010 StandoutScience
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol
2011 Standout
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
2015 Standout
mRNA as novel technology for passive immunotherapy
2018
Leishmaniasis
2018 Standout
Gender medicine and oncology: report and consensus of an ESMO workshop
2019
Quantification of Apixaban's Therapeutic Utility in Prevention of Venous Thromboembolism: Selection of Phase III Trial Dose
2010
Antimicrobial Dosing Considerations in Obese Adult Patients
2007
Selective Targeting of TRPV1 Expressing Sensory Nerve Terminals in the Spinal Cord for Long Lasting Analgesia
2009
Increased major bleeding risk in patients with kidney dysfunction receiving enoxaparin: a meta-analysis
2011
Lsa21, a novel leptospiral protein binding adhesive matrix molecules and present during human infection
2008
Saturated Fatty Acid Activates but Polyunsaturated Fatty Acid Inhibits Toll-like Receptor 2 Dimerized with Toll-like Receptor 6 or 1
2004 Standout
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Electrochemical detection of vascular endothelial growth factors (VEGFs) using VEGF antibody fragments modified Au NPs/ITO electrode
2009
Protective role of phospholipid oxidation products in endotoxin-induced tissue damage
2002 Nature
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
2007 Standout
Vascular disorders of the liver # †
2008 Standout
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
2014 StandoutNobel
Locating proteins in the cell using TargetP, SignalP and related tools
2007 Standout
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
2003 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Designing antimicrobial peptides: form follows function
2011 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
2005 Standout
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract Symptoms, Urodynamic Parameters, and Quality of Life of Patients with Urodynamic Increased Bladder Sensation
2006
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Can innate immunity be enhanced to treat microbial infections?
2004
Anticoagulation During Pregnancy
2016
Ulcerative colitis
2016 Standout
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
2002 Standout
Antibacterial and anti-inflammatory agents that target endotoxin
1998
Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen
2009 Standout
More than just a barrier: urothelium as a drug target for urinary bladder pain
2005
Antibiotic dosing in children in Europe
2012
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
2009 Standout
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
2018 Standout
Integrated control of lower urinary tract – clinical perspective
2006
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Intravesical Neuromodulatory Drugs: Capsaicin and Resiniferatoxin to Treat the Overactive Bladder
2000
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Vanilloid (Capsaicin) Receptors in Health and Disease
2002
Function and Mechanism of Zinc Metalloenzymes
2000 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
2006 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
Therapeutic drug monitoring in patients with inflammatory bowel disease
2014
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
2010 Standout
Gut Microbiota in Health and Disease
2010 Standout
Development of the multi-functionalized gold nanoparticles with electrochemical-based immunoassay for protein A detection
2008
Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice
2008 Standout
Metal Activation of Enzymes in Nucleic Acid Biochemistry
1998
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome
2013
Predicting allopurinol response in patients with gout
2015
Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A
1996
De Novo Design of Potent Antimicrobial Peptides
2004
Solution Structure of Polymyxins B and E and Effect of Binding to Lipopolysaccharide: An NMR and Molecular Modeling Study
1999
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Computerized advice on drug dosage to improve prescribing practice
2008
Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation
2005
Enhanced Antibacterial Potential in UBP43-Deficient Mice against Salmonella typhimurium Infection by Up-Regulating Type I IFN Signaling
2005 StandoutNobel
Gout
2021 Standout
Inflammatory Mechanisms in Obesity
2011 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Real-time Dose Adjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic Cell Transplant: A Bayesian Pharmacokinetic Approach
2006
Lipopolysaccharide Endotoxins
2002 Standout
Origins and Evolution of Antibiotic Resistance
2010 Standout
Euphorbia Diterpenes: Isolation, Structure, Biological Activity, and Synthesis (2008–2012)
2014 Standout
Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis
2012
Andrographolide Attenuates Inflammation by Inhibition of NF-κB Activation through Covalent Modification of Reduced Cysteine 62 of p50
2004 Standout
Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient
2016
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis
2017
Thermodynamics and Structural Studies of the Interaction of Polymyxin B with Deep Rough Mutant Lipopolysaccharides
1999 StandoutNobel
Uridine-Based Inhibitors as New Leads for Antibiotics Targeting Escherichia coli LpxC
2009 StandoutNobel
Type V Protein Secretion Pathway: the Autotransporter Story
2004
Catalytic Hydrolysis of Adenosine 2‘,3‘-Cyclic Monophosphate by CuII Terpyridine
1999 StandoutNobel
Works of Bruce Green being referenced
Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
2010
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation
2006
Quantification of Lean Bodyweight
2005
Intravesical Resiniferatoxin For Refractory Detrusor Hyperreflexia: A Multicenter, Blinded, Randomized, Placebo-Controlled Trial
2003
Prospective Evaluation of a D-Optimal Designed Population Pharmacokinetic Study
2003
A Standard Weight Descriptor for Dose Adjustment in the Obese Patient
2004
The effects of obesity on drug pharmacokinetics in humans
2011
Individualized Dosing of Enoxaparin for Subjects With Renal Impairment Is Superior to Conventional Dosing at Achieving Therapeutic Concentrations
2010
Modelling the occurrence and severity of enoxaparin‐induced bleeding and bruising events
2009
What is the best size descriptor to use for pharmacokinetic studies in the obese?
2004
The Haemophilus influenzae Hap autotransporter mediates microcolony formation and adherence to epithelial cells and extracellular matrix via binding regions in the C-terminal end of the passenger domain
2003
Population Pharmacokinetics of Enoxaparin During the Antenatal Period
2013
INTRAVESICAL RESINIFERATOXIN (RTX) TREATMENT OF DETRUSOR HYPERREFLEXIA
1999
Molecular Mapping and Detoxification of the Lipid A Binding Site by Synthetic Peptides
1993 Science
ANALYSIS OF POPULATION PHARMACOKINETIC DATA USING NONMEM AND WinBUGS
2004
Encouraging the Move Towards Predictive Population Models for the Obese Using Propofol as a Motivating Example
2009